Before the advent of TTM, a prospective study reported that a serum NSE concentration > 33 μg/L on days 1–3 after cardiac arrest was strongly associated with poor neurological outcome (false positive rate [FPR] 0%) [11]. This evidence concerns the gene ENO2 and cardiac arrest.